Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.71 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.66 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.66 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.66 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29472832 | 1.00 | CYP3A4 (0.71) | CYP3A4CYP2D6TAAR1SLC6A4SLC6A2 | |
| SCHEMBL2783585 | 1.00 | CYP3A4 (0.71) | CYP3A4CYP2D6TAAR1SLC6A4SLC6A2 | |
| SCHEMBL2783507 | 1.00 | CYP3A4 (0.71) | CYP3A4CYP2D6TAAR1SLC6A4SLC6A2 | |
| SCHEMBL18132989 | 0.90 | CYP3A4 (0.57) | CYP3A4CYP2D6TAAR1SLC6A4SLC6A2 | |
| SCHEMBL14471389 | 0.85 | TAAR1 (0.68) | CYP3A4CYP2D6TAAR1SLC6A4SLC6A2 | |
| SCHEMBL13003655 | 0.85 | TAAR1 (0.68) | CYP3A4CYP2D6TAAR1SLC6A4SLC6A2 | |
| SCHEMBL23046948 | 0.83 | TAAR1 (0.66) | CYP3A4CYP2D6TAAR1SLC6A4SLC6A2 | |
| SCHEMBL31380295 | 0.83 | TAAR1 (0.71) | CYP3A4CYP2D6TAAR1SLC6A4SLC6A2 | |
| SCHEMBL8585812 | 0.83 | TAAR1 (0.66) | CYP3A4CYP2D6TAAR1SLC6A4SLC6A2 | |
| Dihydrocubebin SCHEMBL15775181 | 0.83 | CYP3A4 (1.00) | CYP3A4CYP2D6TAAR1SLC6A4SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2020225-B1 | Fragrance composition | KAO CORP (JP) | 2014-10-08 | — | — | EP | claimed |
| EP-2258696-A1 | Process for preparing enriched enantiomers of 3-(Benzo[1,3]dioxol-5-yl)-2-methylpropanal | ENDURA S.p.A. (IT) | 2010-12-08 | — | — | EP | claimed |
| EP-2020225-A2 | Fragrance composition | Kao Corporation (JP) | 2009-02-04 | — | — | EP | claimed |
| US-20050245407-A1 | Fragrance composition | KAO CORPORATION (JP) | 2005-11-03 | — | — | US | claimed |
| EP-1552814-A1 | FRAGRANCE COMPOSITION | Kao Corporation (JP) | 2005-07-13 | — | — | EP | claimed |
| US-6727221-B1 | APPLYING TO HUMAN SKIN A PERFUME COMPOSITION COMPRISING AT LEAST 50% BY WEIGHT OF PERFUME COMPONENTS HAVING A MINIMUM INHIBITORY CONCENTRATION (MIC) FOR CORYNEFORM BACTERIA OF GREATER THAN 0.1% | QUEST INTERNATIONAL B.V. (NL) | 2004-04-27 | — | — | US | claimed |
| EP-1094784-B1 | PERFUME COMPOSITION | QUEST INT (NL) | 2004-02-11 | — | — | EP | claimed |
| EP-1094784-A1 | PERFUME COMPOSITION | QUEST INTERNATIONAL B.V. (NL) | 2001-05-02 | — | — | EP | claimed |
| WO-2000001352-A1 | PERFUME COMPOSITION | QUEST INTERNATIONAL B.V. (NL) | 2000-01-13 | — | — | WO | claimed |
| US-20260130959-A1 | FUNGAL EXTRACTS AND FLAVOR COMBINATIONS THEREOF | Mycotechnology, Inc. (US) | 2026-05-14 | — | — | US | disclosed |
| US-20220193162-A1 | FUNGAL EXTRACTS AND FLAVOR COMBINATIONS THEREOF | Mycotechnology, Inc. (US) | 2022-06-23 | — | — | US | disclosed |
| WO-2022102465-A1 | ALDEHYDE COMPOSITION | 三菱瓦斯化学株式会社 | 2022-05-19 | — | — | WO | disclosed |
| EP-3955946-A1 | FUNGAL EXTRACTS AND FLAVOR COMBINATIONS THEREOF | Mycotechnology, Inc. (US) | 2022-02-23 | — | — | EP | disclosed |
| CN-108264642-B | 2-carbonyl acetate-based nano-aroma precursor and application thereof | 华东理工大学 | 2020-11-13 | — | — | CN | disclosed |
| US-6727221-B1 | APPLYING TO HUMAN SKIN A PERFUME COMPOSITION COMPRISING AT LEAST 50% BY WEIGHT OF PERFUME COMPONENTS HAVING A MINIMUM INHIBITORY CONCENTRATION (MIC) FOR CORYNEFORM BACTERIA OF GREATER THAN 0.1% | QUEST INTERNATIONAL B.V. (NL) | 2004-04-27 | — | — | US | disclosed |
| EP-1094784-B1 | PERFUME COMPOSITION | QUEST INT (NL) | 2004-02-11 | — | — | EP | disclosed |
| EP-1094784-A1 | PERFUME COMPOSITION | QUEST INTERNATIONAL B.V. (NL) | 2001-05-02 | — | — | EP | disclosed |
| WO-2000001352-A1 | PERFUME COMPOSITION | QUEST INTERNATIONAL B.V. (NL) | 2000-01-13 | — | — | WO | disclosed |
| EP-0595197-B1 | Enol ethers and odorant compositions containing them | GIVAUDAN ROURE INT (CH) | 1997-04-02 | — | — | EP | disclosed |
| EP-0595197-A1 | Enol ethers and odorant compositions containing them | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1994-05-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260130959-A1 | FUNGAL EXTRACTS AND FLAVOR COMBINATIONS THEREOF | TAS2R8, TAS2R40, TAS1R3 | CYP3A4 2148/4885CYP2D6 4454/4885TAAR1 298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.